• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • 2.0 LPBI Brochure
  • Coronavirus, SARS-CoV-2 Portal
  • Knowledge PORTALS System (KPS)
  • Journal PharmaceuticalIntelligence.com
  • 2020-21 VISTA 1.0 LPBI
  • LPBI Group’s History
  • 2020-21 VISION – 2.0 LPBI
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2020 Summer Internship Portal
  • 2021 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Institutional versus Personal: Statistical Analysis of Two Twitter Handles – @pharma_BI (LPBI Group’s Official) and @AVIVA1950 (LPBI Group’s Founder’s Personal) – Comparative Analysis of Followers and The Followers of these two Handles’ Followers  

Institutional versus Personal: Statistical Analysis of Two Twitter Handles – @pharma_BI (LPBI Group’s Official) and @AVIVA1950 (LPBI Group’s Founder’s Personal) – Comparative Analysis of Followers and The Followers of these two Handles’ Followers  

Visualization Producer: Daniel Menzin

 

 

 

Institutional versus Personal: Statistical Analysis of Two Twitter Handles – @pharma_BI (LPBI Group’s Official) and @AVIVA1950 (LPBI Group’s Founder’s Personal) – Comparative Analysis of Followers and The Followers of these two Handles’ Followers

Curators: Daniel Menzin, Bsc (exp. 5/2021) and Aviva Lev-Ari, PhD, RN

  • Daniel Menzin: Application Developer in Tweepy and Python: Computerized Data Extraction and Analysis
  • Aviva Lev-Ari: Curator of the following manually extracted data sets in collaboration with:

 

  1. Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019
  2. LPBI Group is mostly HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019
  3. Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950 by Alex Crystal and Aviva Lev-Ari
  4. MEDIA organizations as Followers of @pharma_BI the Official Twitter Account of LPBI Group (136 out of 505 Followers): Number of Followers’ Followers, Institutions (I) and Individuals (Persons(P)), RED = Mostly Honored to be followed by
  5. Excerpt of 136 Followers of @pharma_BI (from the List of 505 Followers) by the Number of their Followers on 3/20/2019
  6. Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
  7. REACH – Two Handles on Twitter.com @AVIVA1950 @pharma_BI by Stephen J Williams, PhD
  8. For @AVIVA1950, Founder, LPBI Group @pharma_BI: Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] & Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers] https://analytics.twitter.com/user/AVIVA1950/tweets
  9. The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation
  10. e-Proceedings and Tweet Collections per Conference, 2013-2020, # Views=Downloads x $100: Real Time Coverage of 60 Events by ALA & SJW by Stephen J Williams and Aviva Lev-Ari

 

Comparative Analysis of Followers and The Followers of these two Handles’ Followers: Computerized Data Extraction and Data Analysis

  • @pharma_BI (LPBI Group’s Official) and
  • @AVIVA1950 (LPBI Group’s Founder’s Personal)

Results to be presented by Daniel Menzin on June 16, 2020 at LPBI Group’s Monthly Meeting with External Relations

Having the performed the Computerized Data Extraction on these two handles, it allows LPBI Group to calculate the following measures for our Twitter activities:

1. Summation for each variable = Total Followers per Account and Total for both Accounts

2. Summation for Total Followers’ Followers per Account and Total for both Accounts

3. Calculation of Ratios per Account

3.1 Institutional/total = xx%

3.2 Persons/Total= yy%

3.3 Media/Institutions / Total = zz%

4. Per Account – Segmentation of # Followers

4.1 per Total

4.2 per All Institutions

4.3 per All Persons

4.4 per Media Followers

5. Based on Bio – Manually I will place a start on the 521 Bios, these are “LPBI is Honored to be Followed by”

• They are TARGETED for a narrowcast message to each about

5.1 LPBI proposing to Follow the Journal,

5.2 List of Categories of Research (# articles in Journal’s archive available for download for $30 each)

5.3 Link to our Books, Title Orice Link to each book on Amazon

5.4 List of e-Proceedings LPBI has for download for $100 per Conference

5.5 List of Tweet Collection for Conference LPBI has for download for $100 per event’s Tweet Collection

6. All Media Followers

Targeted for Narrow casting Message

6.1 LPBI’s Portfolio of products

6.2 LPBI request for exploration of Partnership and Collaboration

7. Statistical Analysis

– 2 Bar Diagrams for each Handle one next to the other for all Total and for % above

– line diagrams

– pie diagrams

8. Narrow Casting messages

  • A.  @pharma_BI

a.1 Lists of Institution Followers targeted for Portfolio of Products

a.2 Media Institution targeted for Partnership

a.3 Persons – Proposal to follow the Website

a.4 Persons – Proposal to Publish in the Journal as Guest Author

  • B. @AVIVA1950 – List of Institution Followers targeted for

b.1 = a.1

b.2 = a.2

b.3 = a.3

b.4 = a.4

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Print
  • Email

Like this:

Like Loading...

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,063 other followers

  • Recent Posts

    • National Resilience, Inc. is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption – the Acquisition of Two Premier Biologics Manufacturing Facilities: Boston and in Ontario, Canada March 4, 2021
    • 19 of the 49 New Therapeutic Molecular Entities FDA approved in 2020 — as well as a new Cell-based therapy — are Personalized Medicines March 2, 2021
    • Happy 80th Birthday: Radioiodine (RAI) Theranostics: Collaboration between Physics and Medicine, the Utilization of Radionuclides to Diagnose and Treat: Radiation Dosimetry by Discoverer Dr. Saul Hertz, the early history of RAI in diagnosing and treating Thyroid diseases and Theranostics March 2, 2021
    • 2.0 LPBI is a Very Unique Organization  March 2, 2021
    • FDA emergency use authorization would bring the public a third vaccine for the novel coronavirus – J&J single vaccine – Authorized on 2/28/2021 March 1, 2021
    • Medical Device Representatives coach Surgeons in the Operating Rooms March 1, 2021
    • 2021 Virtual World Medical Innovation Forum, Mass General Brigham, Gene and Cell Therapy, VIRTUAL May 19–21, 2021 February 26, 2021
    • Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysis February 20, 2021
    • First single-course ‘curative’ CRISPR Shot by Intellia rivals Alnylam, Ionis and Pfizer February 19, 2021
    • Contribution of Nervous System Functional Deterioration to late-life Mortality: The Role Neurofilament light chain (NfL) a Blood Biomarker for the Progression of Neurological Diseases and its Correlation to Age and Life Expectancy February 19, 2021
  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.com
    • 2012pharmaceutical
    • Amandeep Kaur
    • Aashir Awan, Phd
    • Adina Hazan
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Daniel Menzin
    • Dror Nir
    • dsmolyar
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jayzmit48
    • jdpmd
    • jshertok
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • Madison Davis
    • marzankhan
    • megbaker58
    • ofermar2020
    • Dr. Pati
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22

Blog at WordPress.com.

WPThemes.


Cancel

 
Loading Comments...
Comment
    ×
    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    %d bloggers like this: